Coursera (NYSE:COUR) reported quarterly sales of $136.40 million which beat the analyst consensus estimate of $128.31 million by 6.31 percent. This is a 24.14 percent increase over sales of $109.88 million the same period last year.
Key Biotech Company Goes All The Way To Reverse Share Split, Here’s What We Know
Psychedelics appear to be here to stay. Yet stocks, shares and finance are another story. On August 4, publicly traded clinical-stage psychedelics firm Mind Medicine Inc.
